MedTrace Logo

Behavioral Resources and Awareness for Veterans With Episodic Migraine: Impact on Neurological Disability and Quality of Life- Pilot

NCT07792291 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-08-31

No results posted yet for this study

Summary

The current study will evaluate effectiveness of cognitive behavioral therapy for migraine compared to migraine education (ME) to improve migraine-related quality of life in the real-world setting of the Veterans Health Administration (VHA).

Conditions

  • Migraine
  • Migraine Headache
  • Episodic Migraine Headache

Interventions

BEHAVIORAL

Cognitive behavioral therapy for migraine (CBTm)

A standardized multi-modal behavioral treatment protocol typically delivered by psychologists via six sessions to help people better manage their migraine through behavior changes, warning sign identification and acute treatment optimization, medication adherence, and restructuring unhelpful thoughts about migraine and stress.

BEHAVIORAL

MEintervention

A digital intervention delivered via six 15-minute remote education sessions with a study research assistant from the VA Connecticut coordination center.

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Jason Sico, MD · VA Connecticut Healthcare System

  • Margaret Bauer, PhD · VA Connecticut Healthcare System

  • Nicholas Rattray, PhD · Richard L. Roudebush VA Medical Center

  • Daniel Rogers, PhD · VA Connecticut Healthcare System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2027-10-31
Completion
2027-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07792291 on ClinicalTrials.gov